Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcoma
Authors:
- 12 May 2013
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 44 (6) , 645-652
Abstract
Chondrosarcoma is the second most common type of bone cancer. Loss of RUNX3 expression has been demonstrated in many other cancers. However, no studies have shown the relationship between RUNX3 expression and chondrosarcoma. In this study, we detected RUNX3 expression in the progression of chondrosarcoma. In patient samples, the levels of RUNX3 mRNA and protein were lower in cancer tissues than in normal tissues. Down-regulation of RUNX3 mRNA in tumor tissues was associated with an increase in RUNX3 promoter methylation. Loss of RUNX3 expression was significantly associated with more aggressive chondrosarcoma types and decreased survival time of patients. To examine the effects of exogenous expression of RUNX3 in vitro, chondrosarcoma cells were transfected with the pcDNA3.1-RUNX3 expression vector. Relative to control cells, RUNX3-expressing cells exhibited lower proliferation and higher apoptosis rates as assessed by colony formation and Annexin V-FITC/PI double staining, respectively. Taken together, these results suggest that RUNX3 acts a tumor suppressor in chondrosarcoma and that RUNX3 promoter methylation may be the molecular mechanism for its decreased expression.Keywords
This publication has 26 references indexed in Scilit:
- Expression and regulation of Runx3 in mouse uterus during the peri-implantation periodJournal of Molecular Histology, 2013
- The role of the tumor suppressor RUNX3 in giant cell tumor of the boneInternational Journal of Oncology, 2011
- Cartilage tumours and bone development: molecular pathology and possible therapeutic targetsNature Reviews Cancer, 2010
- The Clinical Approach Towards ChondrosarcomaThe Oncologist, 2008
- Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancersLung Cancer, 2007
- Expression of RUNX3 protein in human lung adenocarcinoma: Implications for tumor progression and prognosisCancer Science, 2005
- Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinomaLaboratory Investigation, 2004
- Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinomaWorld Journal of Gastroenterology, 2004
- Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancerHuman Molecular Genetics, 2001
- AML1, AML2, and AML3, the Human Members of the runt domain Gene-Family: cDNA Structure, Expression, and Chromosomal LocalizationGenomics, 1994